Twelve-year outcome of Rho-associated protein kinase inhibitor eye drop treatment for Fuchs endothelial corneal dystrophy: A case study.

Tomioka, Yasufumi; Kitazawa, Koji; Fukuoka, Hideki; Ueno, Morio; Koizumi, Noriko; Sotozono, Chie; Kinoshita, Shigeru

Tomioka, Yasufumi; Kitazawa, Koji; Fukuoka, Hideki; Ueno, Morio; Koizumi, Noriko; Sotozono, Chie; Kinoshita, Shigeru.

Afiliação

Tomioka Y; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kitazawa K; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Fukuoka H; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ueno M; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Koizumi N; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Sotozono C; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kinoshita S; Department of Frontier Medical Science and Technology for Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Am J Ophthalmol Case Rep ; 30: 101839, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37096130

Palavras-chave

FECD; ROCK inhibitor; Transcorneal freezing; Y-27632

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Am J Ophthalmol Case Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google